RPL35AP8

Across TCGA pan-cancer cohorts, RPL35AP8 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPL35AP8’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RPL35AP8 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL35AP8 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

STAD, COAD, and UCEC are the cancer types where RPL35AP8 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL35AP8 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	−0.377	.002	6	view →
COAD	All	All	+0.189	.012	3	view →
UCEC	All	IV	+0.535	.030	2	view →
PRAD	All	All	+0.073	.047	2	view →
LUAD	All	All	+0.113	.030	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RPL35AP8–STAD

Open the STAD breakdown →